According to data from the Phase 1b COSMIC-021 clinical trial (NCT03170960), the combination of the multikinase inhibitor cabozantinib (Cabometyx) and the PD-L1 inhibitor atezolizumab (Tecentriq), when used to treat patients…
Thyroid Cancer Treatment Guidelines (2022 Edition) I. OverviewThyroid cancer is a malignant tumor originating from the follicular epithelium or parafollicular epithelium of the thyroid gland, and is the most common…
I. Overview In recent years, the incidence of pancreatic cancer has been increasing significantly both at home and abroad. 2021 statistics show that among all malignant tumors in the United…
Autoimmune Hemolytic Anemia (AIHA) is a group of hemolytic anemias in which abnormal immune function leads to hyperfunction of B cells that produce antibodies to their own red blood cells,…
Formulation and Specifications: Capsules: 20 mgIndications: Pamiparib is indicated for the treatment of patients with recurrent advanced ovarian, fallopian tube, or primary peritoneal cancer with germline BRCA mutations who have…
Formulation and specifications: Capsules: 50mgIndications:1. Maintenance therapy for adult patients with platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after achieving complete remission or partial remission…
Formulation and Specifications: Capsules: 100mgIndications:1. This product is indicated for the maintenance treatment of adult patients with advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after achieving…